Combined lipid-lowering therapy: where we are and where we are going

Abstract

Article discloses combination lipid-lowering therapy, reduce LDL cholesterol level, the microvascular effects of fenofibrate.

Keywords

• Cardiovascular risk
• dyslipidemia
• combination therapy
• statins
• fibrates
• ezetimibe
• PCSK9